Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Auxly Cannabis Group ( (TSE:XLY) ) is now available.
Auxly Cannabis Group reported a strong financial performance for the third quarter of 2025, with net revenues increasing by 20% to $39.9 million and a significant rise in net income by 533% to $20.5 million. The company’s strategic focus on product innovation and cost control has resulted in a 48% increase in Adjusted EBITDA, and the repayment of high-interest debt is expected to save approximately $900,000 in annualized interest expenses, positioning Auxly for continued growth and profitability.
Spark’s Take on TSE:XLY Stock
According to Spark, TipRanks’ AI Analyst, TSE:XLY is a Neutral.
Auxly Cannabis Group’s stock score is primarily driven by its improving financial performance and strong technical indicators. The company’s undervalued P/E ratio further supports a positive outlook. However, ongoing net losses and the absence of a dividend yield are notable risks. The lack of recent earnings call data and corporate events limits additional insights.
To see Spark’s full report on TSE:XLY stock, click here.
More about Auxly Cannabis Group
Auxly Cannabis Group Inc. is a leading consumer packaged goods company in the cannabis products market. The company focuses on product innovation and holds a significant market share as the third largest Canadian Licensed Producer, with its brand Back Forty being the top cannabis brand in Canada.
Average Trading Volume: 954,410
Technical Sentiment Signal: Hold
Current Market Cap: C$236M
For a thorough assessment of XLY stock, go to TipRanks’ Stock Analysis page.